Published January 31, 2014 | Version v1
Journal article

PCDH10 is required for the tumorigenicity of glioblastoma cells

  • 1. Laboratory of Molecular and Genetic Information, Institute of Molecular and Cellular Biosciences, The University of Tokyo, 1-1-1, Yayoi, Bunkyo-ku, Tokyo 113-0032 (Japan)
  • 2. Department of Neurosurgery, Graduate School of Medical Science, Kanazawa University, 13-1, Takara-machi, Kanazawa 920-8641 (Japan)
  • 3. Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033 (Japan)
  • 4. Department of Neurobiology and Anatomy, Kochi Medical School, Kochi University, Okoh-cho, Nangoku-City, Kochi 783-8505 (Japan)
  • 5. Laboratory of Function and Morphology, Institute of Molecular and Cellular Biosciences, The University of Tokyo, 1-1-1, Yayoi, Bunkyo-ku, Tokyo 113-0032 (Japan)
  • 6. Department of Neurosurgery, Faculty of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-8655 (Japan)

Description

Highlights: • PCDH10 is required for the proliferation, survival and self-renewal of glioblastoma cells. • PCDH10 is required for glioblastoma cell migration and invasion. • PCDH10 is required for the tumorigenicity of glioblastoma cells. • PCDH10 may be a promising target for the therapy of glioblastoma. - Abstract: Protocadherin10 (PCDH10)/OL-protocadherin is a cadherin-related transmembrane protein that has multiple roles in the brain, including facilitating specific cell–cell connections, cell migration and axon guidance. It has recently been reported that PCDH10 functions as a tumor suppressor and that its overexpression inhibits proliferation or invasion of multiple tumor cells. However, the function of PCDH10 in glioblastoma cells has not been elucidated. In contrast to previous reports on other tumors, we show here that suppression of the expression of PCDH10 by RNA interference (RNAi) induces the growth arrest and apoptosis of glioblastoma cells in vitro. Furthermore, we demonstrate that knockdown of PCDH10 inhibits the growth of glioblastoma cells xenografted into immunocompromised mice. These results suggest that PCDH10 is required for the proliferation and tumorigenicity of glioblastoma cells. We speculate that PCDH10 may be a promising target for the therapy of glioblastoma

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2013.12.138

Additional details

Identifiers

DOI
10.1016/j.bbrc.2013.12.138;
PII
S0006-291X(13)02209-2;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
444
Journal Issue
1
Journal Page Range
p. 13-18
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
46122141
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
APOPTOSIS; BRAIN; GLIOMAS; IN VITRO; INHIBITION; INTERFERENCE; JOINTS; MICE; NERVE CELLS; PROLIFERATION; RNA; THERAPY; TUMOR CELLS
Descriptors DEC
ANIMAL CELLS; ANIMALS; BODY; CENTRAL NERVOUS SYSTEM; DISEASES; MAMMALS; MEDICINE; NEOPLASMS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; NUCLEIC ACIDS; ORGANIC COMPOUNDS; ORGANS; RODENTS; SOMATIC CELLS; VERTEBRATES

Optional Information

Copyright
Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.